re:cap Competitors

SABIC is a global leader in chemicals headquartered in Riyadh, Saudi Arabia. From making cars and planes more fuel-efficient, to helping conserve the world’s water supply and enabling colorful smartphone cases, we find solutions to the challenges of today to help our customers achieve their ambitions and build a better tomorrow. We support our customers by identifying and developing opportunities in key end markets, such as Hygiene & Healthcare, Electrical & Electronics, Packaging, Agriculture, Consumer Products, and Building & Construction. The company has more than 31,000 employees worldwide, serving customers in more than 140 countries. Fostering innovation and a spirit of ingenuity, SABIC has 11,000 patents and pending applications, and has significant research resources with innovation hubs in five key geographies – Americas, Europe, Middle East, and Asia Pacific. At SABIC, we combine a rich track record of doing what others said couldn’t be done, with a deep understanding of our customers. But our true impact is as a partner who can help our customers achieve their ambitions by finding solutions to their challenges. We call this ‘Chemistry that Matters™’.

Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits. In December 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biosolutions and generate significant value for all stakeholders and society. The combination was completed on January 29, 2024 and Novonesis was born. The name means ‘a new beginning’ and is derived from the Greek word ‘genesis’. It reflects a new era where we’ll better our world with biology. You can find Novonesis on LinkedIn here: linkedin.com/company/novonesis. Novozymes A/S, part of Novonesis Group.

Amyris is a vertically integrated biomanufacturing company that creates specialty molecules for a range of industries, including flavors and fragrances, advanced materials, beauty and personal care, food, and more. Using advanced fermentation technology, Amyris customizes, creates, and manufactures ingredients that enhance lives, protect ecosystems, and take products to the next level of performance. Amyris was founded in 2003 with a bold humanitarian vision to transform access to a lifesaving antimalarial compound using biotechnology. Now, with over two decades of proven commercial success, our proprietary platform is redefining the precision, consistency, and sustainability that is possible with renewable biological chemistry.